Auro Laboratories logo

530233 - Auro Laboratories Share Price

₹53.1 -0.9  -1.7%

Last Trade - 10:17am

Sector
Healthcare
Size
Micro Cap
Market Cap £3.63m
Enterprise Value £3.00m
Revenue £5.25m
Position in Universe 2108th / 3172
Bullish
Bearish
Unlock 530233 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

530233 Revenue Unlock 530233 Revenue

Net Income

530233 Net Income Unlock 530233 Revenue

Normalised EPS

530233 Normalised EPS Unlock 530233 Revenue

PE Ratio Range

530233 PE Ratio Range Unlock 530233 Revenue

Dividend Yield Range

530233 Dividend Yield Range Unlock 530233 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
530233 EPS Forecasts Unlock 530233 Revenue
Profile Summary

Auro Laboratories Limited is engaged in pharmaceuticals business. The Company is involved in the business of bulk drugs. It manufactures active pharmaceutical ingredients (APIs), intermediates and generic formulations. It offers APIs under categories, such as antihistamine, including Chlorpheniramine Maleate; muscle relaxant, including Chlorzoxazone; diuretic, including Frusemide; iron deficiency, including Ferrous Fumarate; anti diabetic, including Glibenclamide, Glimepiride and Gliclazide; anti fungal, including Fluconazole, Ketoconazole and Miconazole; iodine supplement, including Potassium Iodate; antacids, including Aluminium Hydroxide Gel and Magnesium Hydroxid; specialty chemicals, including Guanidine Nitrate and 3,4,5, Trimethoxy Benzoic Acid, and others, including Potassium Iodide, Sodium Iodide and Microcrystalline Cellulose. Its products under intermediates include Glibenclamde Sulphonamide, Cis-bramo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid and 5-Bromo Phthalide.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated May 26, 1989
Public Since March 7, 1995
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Bombay Stock Exchange
Shares in Issue 6,232,500
Free Float (0.0%)
Eligible for
ISAs
SIPPs
530233 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 530233
Upcoming Events for 530233
Similar to 530233
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.